Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Protein

How the cell's waste management systems might be targeted to treat cancer

Human organs and tissues are made up of millions of microscopic living units called cells. Over their lifespans, these cells accumulate waste products that include unwanted, misfolded and surplus proteins.

The Conversation

The human body has 37 trillion cells. If we can work out what they all do, the results could revolutionise healthcare

The average body contains about 37 trillion cells – and we are in the midst of a revolutionary quest to understand what they all do. Unravelling this requires the expertise of scientists from all different backgrounds – computer scientists, biologists, clinicians and mathematicians – as well as new technology and…

The Conversation

This protein powder is being recalled

Mistakenly included in the blend for the impacted items? A "whey-derived flavoring ingredient"

Salon

From analysis to the latest developments in health,
read the most diverse news in one place.

5 Biotechs with $1 Billion in Cash

Worried about a recession? These cashed-up biotech stocks aren't sweating it.

The Street

COVID vaccines: our current shots could soon be updated to target new variants – an immunology expert explains

More than two years into the pandemic, SARS-CoV-2, the virus that causes COVID-19, continues to challenge us. Its ability to rapidly mutate has seen the evolution of increasingly infectious variants that are getting better at hiding from our immune response.

The Conversation

Russian Wheat Prices Down as New Crop Arrives, Export Tax Falls

Russian wheat export prices fell last week due to pressure from the new crop, which farmers have just started harvesting, a reduced export tax and a decline in Chicago prices, analysts said on Monday. Sanctions-hit Russia reduced its grain exports taxes sharply last week to support shipments in the July-June…

Asharq Al-Awsat

Can new Omicron subvariants evade vaccine immunity?

Why COVID cases are rising and what we know about how past infections and vaccines interact with Omicron BA.4 and BA.5.

Al Jazeera

Read news from The Economist, FT, and more,
with one subscription

S.African entrepreneur seeks to turn caterpillars into tasty snacks

Johannesburg (AFP) - A start-up entrepreneur from South Africa wants to change the way edible caterpillars popularly known as "mopane worms" are viewed and eaten.

AFP

Lab-grown answers to food’s triple threat

A severe food crisis could be the impetus for lab-grown and other food alternatives to thrive. But it won’t be without its own challenges, says Élisabeth Abergel

Newsroom.co.nz

JBT Acquires Germany-Based Food Processing Machinery Maker Alco

John Bean Technologies Corp (NYSE:JBT) has acquired Alco-food-machines GmbH & Co. KG, a further food processing solutions and production lines provider, for undisclosed financial terms. Alco was founded in Bad Iburg, Germany, in 1977 based on the idea of Heinz and Gertrud Algra to make the best machines in the industry, which…

Benzinga

France bans 'steak' and 'sausage' labels on vegetarian meats

France is to become the first EU country to stop vegetarian plant-based protein foods from describing themselves as "steak" or "sausage", in a bid to counter increasingly popular meat alternatives.

Radio France Internationale

FDA Expert Panel Favors COVID-19 Boosters Targeting Omicron BA.4, BA.5 Subvariants

The FDA's independent experts voted to include a SARS-CoV-2 omicron component in COVID-19 vaccines that would be used for boosters in the U.S. beginning in fall 2022. The panel has advised manufacturers to develop modified vaccines that add an omicron BA.4/5 spike protein component to the current vaccine composition to create a…

Benzinga

Omega Therapeutics Touts Encouraging Preclinical Data In Liver Cancer Animal Models

Omega Therapeutics Inc (NASDAQ:OMGA) has presented new preclinical data on its lead product candidate, OTX-2002, in multiple models of hepatocellular carcinoma. In non-human primates, treatment with OTX-2002 resulted in a durable reduction of MYC mRNA levels in the liver consistent with previous in vitro and in vivo studies. OTX-2002 treatment decreased c-Myc mRNA,…

Benzinga

NeuroSense Shares Surge On Encouraging Data From Alzheimer's-Associated Biomarker Study

NeuroSense Therapeutics Ltd (NASDAQ:NRSN) has announced results from a biomarker study to evaluate the potential of CogniC, a combination drug for Alzheimer's disease (AD). Earlier this week, NeuroSense reported results from a stage III ALS Biomarker study evaluating PrimeC. Preliminary results showed that levels of disease-related biomarkers in people with ALS were unchanged, in contrast…

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

ABC News

Vegan-friendly lupin goes from livestock feed to rival soy as alternative protein for humans

A regenerative agriculture company opens a processing facility to turn lupins into protein powder as a vegan-friendly alternative to soy.

The Conversation

Feeding insects to cattle could make meat and milk production more sustainable

The world’s population is growing, and so is the challenge of feeding everyone. Current projections indicate that by 2050, global food demand could increase by 59%-98% above current levels. In particular, there will be increased demand for high-quality protein foods, such as meat and dairy products.

The Conversation

Should you get a COVID-19 booster shot now or wait until fall? Two immunologists help weigh the options

While COVID-19 vaccines continue to be highly effective at preventing hospitalization and death, it has become clear that the protection offered by the current vaccines wanes over time. This necessitates the use of booster shots that are safe and effective in enhancing the immune response against the virus and extending…

360info

Lab-grown answers to food’s triple threat

A food crisis like few have ever seen could be the impetus for lab-grown and other food alternatives to thrive. But it won’t be without its own challenges.

Get all your
news in one place.

100’s of premium titles.
One news app.

Daily Mirror

Thor star Natalie Portman's gruelling fitness regime to bulk up for Marvel role

The Oscar winner has bulked up for her role as a superhero in Marvel's Thor: Love and Thunder and had to motivate herself to train during lockdown by downing protein shakes

The Independent UK

Scientists use tadpoles to identify new rare children’s genetic disease

An international team of researchers found that changes in a protein coding gene caused the rare illness.

Benzinga

Intellia's Gene-Editing Candidate Shows Durability In ATTR Amyloidosis

Intellia Therapeutics Inc (NASDAQ:NTLA) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN) announced additional interim data from the Phase 1 study of NTLA-2001, in vivo genome editing candidate for transthyretin (ATTR) amyloidosis. Intellia had said that at the highest dose level (1.0mg/kg), six patients had shown a 93% mean reduction in the toxic protein. In the new data,…

Benzinga

Kroger Plans Dairy Production Expansion - Read More For Details

Kroger Co (NYSE:KR) plans to execute a 35,000 square-foot expansion at Tamarack Farms Dairy to support the implementation of an aseptic milk line. Tamarack Farms Dairy serves about 160 stores in Ohio and West Virginia and provides products for Kroger's e-commerce channel. The facility will be able to manufacture products such as half…

Investors Business Daily

Finally An Omicron-Blocking Shot? Sanofi, GSK Say Yes

Sanofi stock bounded higher Friday after its GSK-partnered Covid shot tamped down on omicron infections in a Phase 3 study.

The Independent UK

Body less able to absorb protein from vegan ‘meat’, study suggests

Findings may lead to development of ingredients to increase uptake of nutrients from plant-based products

Benzinga

UniQure Shares Are Up After Low-Dose Cohort Data From Huntington's Gene Therapy Trial

UniQure N.V. (NASDAQ:QURE) announced safety and biomarker data from 10 patients enrolled in the low-dose cohort of the ongoing Phase 1/2 trial of AMT-130 gene therapy for Huntington's disease. Six of the ten enrolled patients received AMT-130, and four received an imitation surgical procedure in this randomized, blinded clinical trial in the U.S.…

1 … 48 49 50 51

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Office for National Statistics

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Amyotrophic lateral sclerosis

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.